Collaborate closely with the VP of Clinical Development to drive innovative strategies for assigned programs
Oversee the design and execution of clinical trials across all phases, ensuring data integrity, patient safety, and regulatory approval
Lead matrix teams to deliver impactful results while guiding decisions with scientific rigor and medical insight
Serve as Program Lead, guiding core teams, driving program strategy, and preparing submission processes
Ensure patient safety by overseeing medical aspects of studies, conducting risk-benefit assessments, and addressing medical queries
Innovate in trial design, leveraging digital endpoints and real-world evidence to enhance study outcomes
Develop key clinical documents, including Investigator’s Brochures, NDAs, and high-quality Clinical Study Reports
Build strong relationships with external stakeholders while representing the team in governance meetings
Requirements
M.D. degree with a robust scientific and clinical background in Immuno-Oncology or Oncology
Extensive experience leading clinical development programs across Phases I–III, including NDA submissions
Expertise in advanced clinical study designs, companion diagnostics for patient selection, translational modeling, biostatistics, and confirmatory Phase III trial design
Proven experience interacting globally with health authorities (e.g., EMA, FDA), with successful registration being advantageous
Strong medical acumen in monitoring safety/efficacy data and managing patient-centric drug development processes
Exceptional leadership skills to mentor teams while accelerating capabilities through situational management styles.
Benefits
competitive remuneration packages
variety of benefits in support of our diverse employee base